Cargando…
A Humanized Yeast Phenomic Model of Deoxycytidine Kinase to Predict Genetic Buffering of Nucleoside Analog Cytotoxicity
Knowledge about synthetic lethality can be applied to enhance the efficacy of anticancer therapies in individual patients harboring genetic alterations in their cancer that specifically render it vulnerable. We investigated the potential for high-resolution phenomic analysis in yeast to predict such...
Autores principales: | Santos, Sean M., Icyuz, Mert, Pound, Ilya, William, Doreen, Guo, Jingyu, McKinney, Brett A., Niederweis, Michael, Rodgers, John, Hartman, John L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826991/ https://www.ncbi.nlm.nih.gov/pubmed/31575041 http://dx.doi.org/10.3390/genes10100770 |
Ejemplares similares
-
Yeast Phenomics: An Experimental Approach for Modeling Gene Interaction Networks that Buffer Disease
por: Hartman, John L., et al.
Publicado: (2015) -
A yeast phenomic model for the influence of Warburg metabolism on genetic buffering of doxorubicin
por: Santos, Sean M., et al.
Publicado: (2019) -
A yeast phenomic model for the gene interaction network modulating CFTR-ΔF508 protein biogenesis
por: Louie, Raymond J, et al.
Publicado: (2012) -
Structural basis for activation of the therapeutic l-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase
por: Sabini, Elisabetta, et al.
Publicado: (2007) -
Targeted Delivery of Deoxycytidine Kinase to Her2-Positive Cells Enhances the Efficacy of the Nucleoside Analog Fludarabine
por: Koduvayur, Sujatha P., et al.
Publicado: (2016)